Research Article
Empirical Study on the Transparency of Security Risk Information in Chinese Listed Pharmaceutical Enterprises Based on the ANP-DS Method
Table 11
Standardized value of the index evaluation weight.
| First-level index | Weight | Second-level index | Weight | Third-level index | Weight |
| A1 | 0.950 | B1 | 0.950 | C11 | 0.465 | C12 | 0.465 | C13 | 0.950 | C14 | 0.393 | C15 | 0.233 | C16 | 0.278 | B2 | 0.196 | C21 | 0.854 | C22 | 0.388 | C23 | 0.950 | C24 | 0.854 | B3 | 0.117 | C31 | 0.950 | C32 | 0.950 | C33 | 0.950 | C34 | 0.950 | B4 | 0.828 | C41 | 0.950 | C42 | 0.950 | C43 | 0.950 | C44 | 0.950 |
| A2 | 0.475 | B5 | 0.088 | C51 | 0.950 | C52 | 0.950 | C53 | 0.950 | C54 | 0.950 | B6 | 0.414 | C61 | 0.950 | C62 | 0.317 | C63 | 0.317 | C64 | 0.317 | B7 | 0.224 | C71 | 0.950 | C72 | 0.950 | C73 | 0.950 | C74 | 0.950 | B8 | 0.684 | C81 | 0.441 | C82 | 0.881 | C83 | 0.881 | C84 | 0.950 | C85 | 0.414 | C86 | 0.441 | B9 | 0.950 | C91 | 0.950 | C92 | 0.950 | C93 | 0.950 | C94 | 0.950 |
|
|